Vectura and Hikma have extended their partnership, signing an agreement to develop a generic of GlaxoSmithKline’s asthma drug, Serevent, for the US market. The product is codenamed VR730 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback